Publications by authors named "A Virano"
Article Synopsis
- - The study investigated whether administering heparin in hospitals improves survival rates among COVID-19 patients, due to a linked hypercoagulable condition that can worsen the disease.
- - An analysis of 2,574 patients across Italy showed that 70.1% received heparin, leading to significantly lower death rates (7.4 vs. 14.0 per 1,000 person-days) among those treated with heparin.
- - The findings suggest that heparin is associated with a 40% reduction in death risk, especially for critically ill patients, indicating its potential benefit, although further randomized clinical trials are necessary for definitive guidance.
Article Synopsis
- The study compared coagulation parameters and rates of venous thromboembolic events (VTE) in COVID-19 patients versus non-COVID-19 patients with acute respiratory insufficiency.
- About half of the 324 patients studied had COVID-19, showing distinct differences in white blood cell counts and inflammatory markers, but similar D-dimer levels between both groups.
- Findings indicated that while D-dimer levels were elevated in both groups, there were very few cases of deep vein thrombosis or pulmonary embolism detected at admission, with no significant difference between COVID-19 and non-COVID-19 patients.
Background: Intracranial haemorrhage (ICH) risk after minor traumatic brain injury (mTBI) in patients on antithrombotic treatment is unclear. We compared ICH rates in mTBI patients on single, double and no antithrombotic therapy. Antithrombotic drugs encompassed vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs) and antiplatelets.
View Article and Find Full Text PDF